Age-related modulation of plasmatic beta-Galactosidase activity in healthy subjects and in patients affected by T2DM
β-Galactosidase (β-Gal) activity has been the most extensively utilized biomarker for the detection of cellular senescence. It can be measured also in plasma, and few recent evidence showed an altered plasmatic β-Gal activity in patients affected by some age-related diseases (ARDs). Since T2DM is on...
Saved in:
| Published in | Oncotarget Vol. 8; no. 55; pp. 93338 - 93348 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Impact Journals LLC
07.11.2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1949-2553 1949-2553 |
| DOI | 10.18632/oncotarget.21848 |
Cover
Loading…
| Abstract | β-Galactosidase (β-Gal) activity has been the most extensively utilized biomarker for the detection of cellular senescence. It can be measured also in plasma, and few recent evidence showed an altered plasmatic β-Gal activity in patients affected by some age-related diseases (ARDs). Since T2DM is one of the most common ARDs, we aimed to investigate if plasmatic β-Gal activity is modulated in T2DM patients and if "age" could affect such modulation. To gain mechanistic insights we paralleled this investigation with the evaluation of β-Gal activity in young and senescent endothelial cells (HUVECs) cultured in normo- and hyper-glycaemic environment. A significant age-related increase of plasmatic β-Gal activity was observed in healthy subjects (n. 230; 55-87 years), whereas the enzymatic activity was significantly reduced in T2DM patients (n. 230; 55-96 years) compared to healthy subjects. β-Gal activity detectable both in cells and in the culture medium was significantly increased in senescent cells compared to the younger ones, both under normo- and hyper-glycaemic condition. However, the hyper-glycaemic condition was not associated with an increased β-Gal activity in milieu compared to normo-glycaemic condition. Overall our data reinforce the notion that plasmatic β-Gal activity could be a systemic biomarker of aging, whereas T2DM patients are characterized by a different age-releated trend. |
|---|---|
| AbstractList | β-Galactosidase (β-Gal) activity has been the most extensively utilized biomarker for the detection of cellular senescence. It can be measured also in plasma, and few recent evidence showed an altered plasmatic β-Gal activity in patients affected by some age-related diseases (ARDs). Since T2DM is one of the most common ARDs, we aimed to investigate if plasmatic β-Gal activity is modulated in T2DM patients and if "age" could affect such modulation. To gain mechanistic insights we paralleled this investigation with the evaluation of β-Gal activity in young and senescent endothelial cells (HUVECs) cultured in normo- and hyper-glycaemic environment. A significant age-related increase of plasmatic β-Gal activity was observed in healthy subjects (n. 230; 55-87 years), whereas the enzymatic activity was significantly reduced in T2DM patients (n. 230; 55-96 years) compared to healthy subjects. β-Gal activity detectable both in cells and in the culture medium was significantly increased in senescent cells compared to the younger ones, both under normo- and hyper-glycaemic condition. However, the hyper-glycaemic condition was not associated with an increased β-Gal activity in milieu compared to normo-glycaemic condition. Overall our data reinforce the notion that plasmatic β-Gal activity could be a systemic biomarker of aging, whereas T2DM patients are characterized by a different age-releated trend. β-Galactosidase (β-Gal) activity has been the most extensively utilized biomarker for the detection of cellular senescence. It can be measured also in plasma, and few recent evidence showed an altered plasmatic β-Gal activity in patients affected by some age-related diseases (ARDs). Since T2DM is one of the most common ARDs, we aimed to investigate if plasmatic β-Gal activity is modulated in T2DM patients and if “age” could affect such modulation. To gain mechanistic insights we paralleled this investigation with the evaluation of β-Gal activity in young and senescent endothelial cells (HUVECs) cultured in normo- and hyper-glycaemic environment. A significant age-related increase of plasmatic β-Gal activity was observed in healthy subjects (n. 230; 55-87 years), whereas the enzymatic activity was significantly reduced in T2DM patients (n. 230; 55-96 years) compared to healthy subjects. β-Gal activity detectable both in cells and in the culture medium was significantly increased in senescent cells compared to the younger ones, both under normo- and hyper-glycaemic condition. However, the hyper-glycaemic condition was not associated with an increased β-Gal activity in milieu compared to normo-glycaemic condition. Overall our data reinforce the notion that plasmatic β-Gal activity could be a systemic biomarker of aging, whereas T2DM patients are characterized by a different age-releated trend. β-Galactosidase (β-Gal) activity has been the most extensively utilized biomarker for the detection of cellular senescence. It can be measured also in plasma, and few recent evidence showed an altered plasmatic β-Gal activity in patients affected by some age-related diseases (ARDs). Since T2DM is one of the most common ARDs, we aimed to investigate if plasmatic β-Gal activity is modulated in T2DM patients and if "age" could affect such modulation. To gain mechanistic insights we paralleled this investigation with the evaluation of β-Gal activity in young and senescent endothelial cells (HUVECs) cultured in normo- and hyper-glycaemic environment. A significant age-related increase of plasmatic β-Gal activity was observed in healthy subjects (n. 230; 55-87 years), whereas the enzymatic activity was significantly reduced in T2DM patients (n. 230; 55-96 years) compared to healthy subjects. β-Gal activity detectable both in cells and in the culture medium was significantly increased in senescent cells compared to the younger ones, both under normo- and hyper-glycaemic condition. However, the hyper-glycaemic condition was not associated with an increased β-Gal activity in milieu compared to normo-glycaemic condition. Overall our data reinforce the notion that plasmatic β-Gal activity could be a systemic biomarker of aging, whereas T2DM patients are characterized by a different age-releated trend.β-Galactosidase (β-Gal) activity has been the most extensively utilized biomarker for the detection of cellular senescence. It can be measured also in plasma, and few recent evidence showed an altered plasmatic β-Gal activity in patients affected by some age-related diseases (ARDs). Since T2DM is one of the most common ARDs, we aimed to investigate if plasmatic β-Gal activity is modulated in T2DM patients and if "age" could affect such modulation. To gain mechanistic insights we paralleled this investigation with the evaluation of β-Gal activity in young and senescent endothelial cells (HUVECs) cultured in normo- and hyper-glycaemic environment. A significant age-related increase of plasmatic β-Gal activity was observed in healthy subjects (n. 230; 55-87 years), whereas the enzymatic activity was significantly reduced in T2DM patients (n. 230; 55-96 years) compared to healthy subjects. β-Gal activity detectable both in cells and in the culture medium was significantly increased in senescent cells compared to the younger ones, both under normo- and hyper-glycaemic condition. However, the hyper-glycaemic condition was not associated with an increased β-Gal activity in milieu compared to normo-glycaemic condition. Overall our data reinforce the notion that plasmatic β-Gal activity could be a systemic biomarker of aging, whereas T2DM patients are characterized by a different age-releated trend. |
| Author | Zampini, Lucia Procopio, Antonio Domenico Boemi, Massimo Olivieri, Fabiola Galeazzi, Tiziana Spazzafumo, Liana Testa, Roberto Bonafè, Massimiliano Prattichizzo, Francesco Antonicelli, Roberto Bonfigli, Anna Rita Mensà, Emanuela Garagnani, Paolo Matacchione, Giulia Marcheselli, Fiorella Recchioni, Rina |
| Author_xml | – sequence: 1 givenname: Liana surname: Spazzafumo fullname: Spazzafumo, Liana organization: Center of Biostatics, INRCA-IRCCS National Institute, Ancona, Italy – sequence: 2 givenname: Emanuela surname: Mensà fullname: Mensà, Emanuela organization: Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy – sequence: 3 givenname: Giulia surname: Matacchione fullname: Matacchione, Giulia organization: Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy – sequence: 4 givenname: Tiziana surname: Galeazzi fullname: Galeazzi, Tiziana organization: Pediatric Division, Department of Clinical Sciences, Università Politecnica delle Marche, Ospedali Riuniti, Presidio Salesi, Ancona, Italy – sequence: 5 givenname: Lucia surname: Zampini fullname: Zampini, Lucia organization: Pediatric Division, Department of Clinical Sciences, Università Politecnica delle Marche, Ospedali Riuniti, Presidio Salesi, Ancona, Italy – sequence: 6 givenname: Rina surname: Recchioni fullname: Recchioni, Rina organization: Center of Clinical Pathology and Innovative Therapy, INRCA-IRCCS National Institute, Ancona, Italy – sequence: 7 givenname: Fiorella surname: Marcheselli fullname: Marcheselli, Fiorella organization: Center of Clinical Pathology and Innovative Therapy, INRCA-IRCCS National Institute, Ancona, Italy – sequence: 8 givenname: Francesco surname: Prattichizzo fullname: Prattichizzo, Francesco organization: Department of Cardiovascular and Metabolic Diseases, IRCCS Multimedica, Sesto San Giovanni, Italy – sequence: 9 givenname: Roberto surname: Testa fullname: Testa, Roberto organization: Clinical Laboratory and Molecular Diagnostics, INRCA-IRCCS National Institute, Ancona, Italy – sequence: 10 givenname: Roberto surname: Antonicelli fullname: Antonicelli, Roberto organization: UTIC-Cardiology INRCA-IRCCS, National Institute, Ancona, Italy – sequence: 11 givenname: Paolo surname: Garagnani fullname: Garagnani, Paolo organization: Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy, Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden – sequence: 12 givenname: Massimo surname: Boemi fullname: Boemi, Massimo organization: Diabetology Unit, INRCA-IRCCS, National Institute, Ancona, Italy – sequence: 13 givenname: Massimiliano surname: Bonafè fullname: Bonafè, Massimiliano organization: Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy – sequence: 14 givenname: Anna Rita surname: Bonfigli fullname: Bonfigli, Anna Rita organization: Scientific Direction, INRCA-IRCCS, National Institute, Ancona, Italy – sequence: 15 givenname: Antonio Domenico surname: Procopio fullname: Procopio, Antonio Domenico organization: Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy, Center of Clinical Pathology and Innovative Therapy, INRCA-IRCCS National Institute, Ancona, Italy – sequence: 16 givenname: Fabiola surname: Olivieri fullname: Olivieri, Fabiola organization: Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy, Center of Clinical Pathology and Innovative Therapy, INRCA-IRCCS National Institute, Ancona, Italy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29212153$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1UU1v3CAURFWiJk3zA3qpOPbiFDAGc6kUJW1aKVUuyRlh_NglwrA1ONL--7Kbj6aVyoV5jzcz6M07dBBTBIQ-UHJGe9GyzynaVMy8gnLGaM_7N-iYKq4a1nXtwSt8hE5zvif1dFz2TL1FR0wxymjXHqNyvoJmhmAKjHhK41KRTxEnhzfB5KlWFg9QTHNlgrElZT-aDLhC_-DLFvuI12BCWW9xXoZ7sCVjE8ddf1PJEHe1c7VfDYYtvmWXP9-jQ2dChtOn-wTdfft6e_G9ub65-nFxft1Y3srSWEk76YwiMFgYpXXABwO9EdT1Fri0nWBAxAhSCjHKngNVrBWEtZw60pn2BH151N0swwSjrZ-ZTdCb2U9m3upkvP77Jfq1XqUH3UkipFJV4NOTwJx-LZCLnny2EIKJkJasqZKcUE7EbvTja68Xk-dV1wH5OGDnlPMMTltf9suu1j5oSvQ-V_0nV73PtTLpP8xn8f9zfgNgqKx4 |
| CitedBy_id | crossref_primary_10_1016_j_ebiom_2019_01_025 crossref_primary_10_1055_a_1381_6625 crossref_primary_10_1038_s41467_024_47279_4 crossref_primary_10_18632_aging_102872 crossref_primary_10_3389_fimmu_2023_1188838 crossref_primary_10_3390_ijms25126337 crossref_primary_10_1016_j_mad_2019_03_001 crossref_primary_10_3390_cells10030502 crossref_primary_10_1371_journal_ppat_1008528 crossref_primary_10_18087_cardio_2022_6_n2033 crossref_primary_10_3389_fragi_2021_708788 crossref_primary_10_1016_j_scitotenv_2019_06_391 crossref_primary_10_3390_jcm8050720 crossref_primary_10_3389_fcvm_2022_953582 crossref_primary_10_1186_s43162_023_00209_0 crossref_primary_10_1002_pmic_201900408 crossref_primary_10_3389_fcell_2022_946678 crossref_primary_10_1016_j_cca_2022_08_006 crossref_primary_10_3390_life11030229 crossref_primary_10_1039_D1AY00470K |
| Cites_doi | 10.1073/pnas.92.20.9363 10.1196/annals.1395.035 10.1093/jb/mvj126 10.1111/j.1464-5491.2011.03370.x 10.3233/JAD-2001-3114 10.1016/j.ceb.2015.04.016 10.1371/journal.pone.0119983 10.1093/glycob/cwv172 10.2337/db16-1009 10.1016/j.exger.2010.08.009 10.1074/jbc.M111.293795 10.1038/nm.4000 10.3233/JAD-2011-100525 10.1016/j.biocel.2014.11.001 10.1016/0305-0491(85)90303-7 10.1111/j.1447-0594.2006.00341.x 10.1016/j.ebiom.2017.03.046 10.1111/j.1474-9726.2006.00199.x 10.1073/pnas.1515464112 10.1016/j.arr.2009.05.001 10.1111/acel.12325 10.1016/j.arr.2012.02.002 10.1111/j.1749-6632.2000.tb06651.x 10.1007/s11357-011-9348-8 10.18632/oncotarget.5899 10.2337/db14-1820 10.18632/oncotarget.7059 10.1016/j.biochi.2011.09.021 10.1093/gerona/glt190 10.4049/jimmunol.0802577 10.1016/j.ebiom.2017.04.013 10.1007/978-1-59745-361-5_3 10.1038/nm.2862 10.1007/s11357-012-9440-8 10.1016/0003-2697(76)90527-3 10.1016/0009-8981(79)90346-2 10.5603/FHC.2012.0036 10.1016/j.arr.2016.04.009 10.1074/jbc.M303030200 10.1021/acs.jproteome.5b00052 10.1093/gerona/57.1.B16 10.1161/01.RES.0000121104.05977.F3 10.1016/j.bbadis.2011.03.018 10.1155/2016/1810327 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2017 Spazzafumo et al. 2017 |
| Copyright_xml | – notice: Copyright: © 2017 Spazzafumo et al. 2017 |
| DBID | AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.18632/oncotarget.21848 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 1949-2553 |
| EndPage | 93348 |
| ExternalDocumentID | PMC5706799 29212153 10_18632_oncotarget_21848 |
| Genre | Journal Article |
| GroupedDBID | --- 53G AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK FRJ GX1 HYE KQ8 M48 OK1 PGMZT RPM M~E NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c437t-c7157fa90ebced7cfe4bae8a61f8ce47c562e06de7766d784e1923602341f05a3 |
| IEDL.DBID | M48 |
| ISSN | 1949-2553 |
| IngestDate | Thu Aug 21 18:12:59 EDT 2025 Fri Jul 11 10:55:25 EDT 2025 Wed Feb 19 02:42:26 EST 2025 Thu Apr 24 23:07:14 EDT 2025 Thu Jul 03 08:20:02 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 55 |
| Keywords | inflammaging Gerotarget cellular senescence type 2 diabetes aging beta galactosidase activity |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c437t-c7157fa90ebced7cfe4bae8a61f8ce47c562e06de7766d784e1923602341f05a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The authors contributed equally to this work |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.18632/oncotarget.21848 |
| PMID | 29212153 |
| PQID | 1974014069 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5706799 proquest_miscellaneous_1974014069 pubmed_primary_29212153 crossref_citationtrail_10_18632_oncotarget_21848 crossref_primary_10_18632_oncotarget_21848 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-11-07 |
| PublicationDateYYYYMMDD | 2017-11-07 |
| PublicationDate_xml | – month: 11 year: 2017 text: 2017-11-07 day: 07 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Oncotarget |
| PublicationTitleAlternate | Oncotarget |
| PublicationYear | 2017 |
| Publisher | Impact Journals LLC |
| Publisher_xml | – name: Impact Journals LLC |
| References | Hoeijmakers (26) 2010; 45 Franceschi (27) 2013; 12 Zwierz (25) 2012; 50 Sarac (41) 2014; 69 Hess (43) 2012; 18 Bradford (48) 1976; 72 Bajorek (30) 2014; 12 Orlacchio (7) 2011; 24 Franceschi (11) 2015; 14 Brakowiecki (6) 2001; 52 van Deursen (22) 2015; 21 Dewaele (28) 2015; 10 Pereira-Smith (16) 1995; 92 Emiliani (12) 2012; 94 Tchkonia (31) 2017; 21 Zwierz (24) 2008; 55 Procopio (46) 2011; 28 Deretic (15) 2015; 35 Hägg (42) 2017; 21 Simonati (2) 2011; 1812 Sani (49) 1979; 95 Ruckenstuhl (4) 2016; 32 Emiliani (10) 2015; 58 Ceriello (33) 2016; 2016 Zwierz (23) 2010; 48 VAN Heemst (20) 2007; 1100 Arden (35) 2017; 66 Hoenderop (40) 2016; 26 Hwang (17) 2006; 5 Griffiths (13) 2006; 140 Dimri (18) 2007; 371 Bonafè (21) 2015; 6 Antonicelli (38) 2013; 35 Marth (39) 2015; 112 Bossis (3) 2009; 8 Kirkland (32) 2015; 64 Vasto (34) 2013; 35 De Benedictis (45) 2000; 908 Cosović (9) 2002; 57 Reglero (36) 1985; 80 Cataldo (5) 2001; 3 Orlacchio (8) 2003; 278 Sawabe (29) 2006; 6 Dimmeler (47) 2004; 94 Shimizu (1) 2012; 287 Nelson (37) 2015; 14 Mosieniak (19) 2014; 12 Hashimoto (14) 2009; 182 Dall’Olio (44) 2016; 7 |
| References_xml | – volume: 48 start-page: 351 year: 2010 ident: 23 article-title: Lysosomal exoglycosidases in serum and urine of patients with pancreatic adenocarcinoma publication-title: Folia Histochem Cytobiol – volume: 92 start-page: 9363 year: 1995 ident: 16 article-title: A biomarker that identifies senescent human cells in culture and in aging skin in vivo publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.92.20.9363 – volume: 1100 start-page: 323 year: 2007 ident: 20 article-title: Beta-galactosidase activity as a biomarker of replicative senescence during the course of human fibroblast cultures publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1395.035 – volume: 140 start-page: 7 year: 2006 ident: 13 article-title: Regulating secretory lysosomes publication-title: J Biochem doi: 10.1093/jb/mvj126 – volume: 28 start-page: 1388 year: 2011 ident: 46 article-title: Leukocyte telomere length is associated with complications of type 2 diabetes mellitus publication-title: Diabet Med doi: 10.1111/j.1464-5491.2011.03370.x – volume: 3 start-page: 97 year: 2001 ident: 5 article-title: The neuronal endosomal-lysosomal system in Alzheimer’s disease publication-title: J Alzheimers Dis doi: 10.3233/JAD-2001-3114 – volume: 35 start-page: 106 year: 2015 ident: 15 article-title: Secretory autophagy publication-title: Curr Opin Cell Biol doi: 10.1016/j.ceb.2015.04.016 – volume: 10 start-page: e0119983 year: 2015 ident: 28 article-title: N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters publication-title: PLoS One doi: 10.1371/journal.pone.0119983 – volume: 26 start-page: 472 year: 2016 ident: 40 article-title: Urinary β-galactosidase stimulates Ca2+ transport by stabilizing TRPV5 at the plasma membrane publication-title: Glycobiology doi: 10.1093/glycob/cwv172 – volume: 66 start-page: 1272 year: 2017 ident: 35 article-title: Glucagon-like Peptide-1 Protects Pancreatic Beta-cells from Death by Increasing Autophagic Flux and Restoring Lysosomal Function publication-title: Diabetes doi: 10.2337/db16-1009 – volume: 45 start-page: 738 year: 2010 ident: 26 article-title: Serum N-glycan profile shift during human ageing publication-title: Exp Gerontol doi: 10.1016/j.exger.2010.08.009 – volume: 287 start-page: 1801 year: 2012 ident: 1 article-title: Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases publication-title: J Biol Chem doi: 10.1074/jbc.M111.293795 – volume: 21 start-page: 1424 year: 2015 ident: 22 article-title: Cellular senescence in aging and age-related disease: from mechanisms to therapy publication-title: Nat Med doi: 10.1038/nm.4000 – volume: 24 start-page: 785 year: 2011 ident: 7 article-title: Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer’s disease and type 2 diabetes mellitus publication-title: J Alzheimers Dis doi: 10.3233/JAD-2011-100525 – volume: 58 start-page: 62 year: 2015 ident: 10 article-title: Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer’s disease progression publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2014.11.001 – volume: 80 start-page: 629 year: 1985 ident: 36 article-title: Carbohydrate contents, and glycosidase and glycosyl transferase activities in tissues from streptozotocin diabetic mice publication-title: Comp Biochem Physiol B doi: 10.1016/0305-0491(85)90303-7 – volume: 52 start-page: 823 year: 2001 ident: 6 article-title: Changes in pancreatic lysosomal enzymes activity as the potential factors leading to diabetic enteropathy publication-title: J Physiol Pharmacol – volume: 6 start-page: 149 year: 2006 ident: 29 article-title: Reviewing the definition of “elderly” publication-title: Geriatr Gerontol Int doi: 10.1111/j.1447-0594.2006.00341.x – volume: 21 start-page: 29 year: 2017 ident: 42 article-title: Biological Age Predictors publication-title: EBioMedicine doi: 10.1016/j.ebiom.2017.03.046 – volume: 5 start-page: 187 year: 2006 ident: 17 article-title: Senescence-associated beta-galactosidase is lysosomal beta-galactosidase publication-title: Aging Cell doi: 10.1111/j.1474-9726.2006.00199.x – volume: 112 start-page: 13657 year: 2015 ident: 39 article-title: An intrinsic mechanism of secreted protein aging and turnover publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1515464112 – volume: 8 start-page: 199 year: 2009 ident: 3 article-title: Aging: central role for autophagy and the lysosomal degradative system publication-title: Ageing Res Rev doi: 10.1016/j.arr.2009.05.001 – volume: 12 start-page: 698 year: 2014 ident: 19 article-title: Cellular senescence in ageing, age-related disease and longevity publication-title: Curr Vasc Pharmacol – volume: 14 start-page: 491 year: 2015 ident: 11 article-title: Accelerated epigenetic aging in Down syndrome publication-title: Aging Cell doi: 10.1111/acel.12325 – volume: 12 start-page: 685 year: 2013 ident: 27 article-title: N-glycomic biomarkers of biological aging and longevity: a link with inflammaging publication-title: Ageing Res Rev doi: 10.1016/j.arr.2012.02.002 – volume: 908 start-page: 244 year: 2000 ident: 45 article-title: Inflamm-aging. An evolutionary perspective on immunosenescence publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2000.tb06651.x – volume: 35 start-page: 419 year: 2013 ident: 34 article-title: Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes publication-title: Age (Dordr) doi: 10.1007/s11357-011-9348-8 – volume: 6 start-page: 35509 year: 2015 ident: 21 article-title: DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging publication-title: Oncotarget doi: 10.18632/oncotarget.5899 – volume: 64 start-page: 2289 year: 2015 ident: 32 article-title: Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity publication-title: Diabetes doi: 10.2337/db14-1820 – volume: 7 start-page: 7455 year: 2016 ident: 44 article-title: Identification of novel plasma glycosylation-associated markers of aging publication-title: Oncotarget doi: 10.18632/oncotarget.7059 – volume: 94 start-page: 684 year: 2012 ident: 12 article-title: Glycohydrolases β-hexosaminidase and β-galactosidase are associated with lipid microdomains of Jurkat T-lymphocytes publication-title: Biochimie doi: 10.1016/j.biochi.2011.09.021 – volume: 69 start-page: 779 year: 2014 ident: 41 article-title: Glycans are a novel biomarker of chronological and biological ages publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glt190 – volume: 182 start-page: 2051 year: 2009 ident: 14 article-title: The activation of P2X7 receptor impairs lysosomal functions and stimulates the release of autophagolysosomes in microglial cells publication-title: J Immunol doi: 10.4049/jimmunol.0802577 – volume: 21 start-page: 21 year: 2017 ident: 31 article-title: Cellular Senescence: A Translational Perspective publication-title: EBioMedicine doi: 10.1016/j.ebiom.2017.04.013 – volume: 55 start-page: 921 year: 2008 ident: 24 article-title: Lysosomal exoglycosidases in serum and urine of patients with colon adenocarcinoma publication-title: Hepatogastroenterology – volume: 371 start-page: 21 year: 2007 ident: 18 article-title: Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay publication-title: Methods Mol Biol doi: 10.1007/978-1-59745-361-5_3 – volume: 18 start-page: 1401 year: 2012 ident: 43 article-title: Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1 publication-title: Nat Med doi: 10.1038/nm.2862 – volume: 35 start-page: 1157 year: 2013 ident: 38 article-title: MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling publication-title: Age (Dordr) doi: 10.1007/s11357-012-9440-8 – volume: 72 start-page: 248 year: 1976 ident: 48 article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding publication-title: Anal Biochem doi: 10.1016/0003-2697(76)90527-3 – volume: 95 start-page: 135 year: 1979 ident: 49 article-title: Glycosaminoglycans from urine and tissues in mucolipidosis II (I-cell disease) publication-title: Clin Chim Acta doi: 10.1016/0009-8981(79)90346-2 – volume: 50 start-page: 270 year: 2012 ident: 25 article-title: Alpha fucosidase and beta galactosidase in serum of a Lyme disease patients as a possible marker of accelerated senescence - a preliminary study publication-title: Folia Histochem Cytobiol doi: 10.5603/FHC.2012.0036 – volume: 32 start-page: 2 year: 2016 ident: 4 article-title: The crucial impact of lysosomes in aging and longevity publication-title: Ageing Res Rev doi: 10.1016/j.arr.2016.04.009 – volume: 278 start-page: 38453 year: 2003 ident: 8 article-title: Up-regulation of glycohydrolases in Alzheimer’s Disease fibroblasts correlates with Ras activation publication-title: J Biol Chem doi: 10.1074/jbc.M303030200 – volume: 14 start-page: 3123 year: 2015 ident: 37 article-title: Quantitative Differences in the Urinary Proteome of Siblings Discordant for Type 1 Diabetes Include Lysosomal Enzymes publication-title: J Proteome Res doi: 10.1021/acs.jproteome.5b00052 – volume: 57 start-page: B16 year: 2002 ident: 9 article-title: Leukocyte lysosomal enzymes in Alzheimer’s disease and Down’s syndrome publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/57.1.B16 – volume: 12 start-page: 489 year: 2014 ident: 30 article-title: Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy publication-title: Pharm Pract (Granada) – volume: 94 start-page: 768 year: 2004 ident: 47 article-title: Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells publication-title: Circ Res doi: 10.1161/01.RES.0000121104.05977.F3 – volume: 1812 start-page: 782 year: 2011 ident: 2 article-title: GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings publication-title: Biochim Biophys Acta doi: 10.1016/j.bbadis.2011.03.018 – volume: 2016 start-page: 1810327 year: 2016 ident: 33 article-title: “Inflammaging” as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 Diabetes publication-title: Oxid Med Cell Longev doi: 10.1155/2016/1810327 |
| SSID | ssj0000547829 |
| Score | 2.2897186 |
| Snippet | β-Galactosidase (β-Gal) activity has been the most extensively utilized biomarker for the detection of cellular senescence. It can be measured also in plasma,... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 93338 |
| SubjectTerms | Research Paper: Gerotarget (Focus on Aging) |
| Title | Age-related modulation of plasmatic beta-Galactosidase activity in healthy subjects and in patients affected by T2DM |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29212153 https://www.proquest.com/docview/1974014069 https://pubmed.ncbi.nlm.nih.gov/PMC5706799 |
| Volume | 8 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT9wwELWAXrhUoBa65UOu1FMlQ2J77eSAEGoLqNL2xEp7i2xn3CItCWWzEvvvmUmyS7elPSaxHSnP1ptxPO8x9tGXUWmfOCFV9EI7a0SeayOQXGU0IUQbqMB59N1cj_W3yXCywZb2Vv0HnL2Y2pGf1PhhevL4a3GOC_6MFnxmlDytScegPTh9QhlLtsleITFZcnIY9dF-J_WtkQ_z_t_miz1JGziXpLig1onqr-jzz0OUv7HS5Q573YeT_KLDf5dtQPWGNRc_QLRFKlDyu7rsHbp4Hfk9BsutSCv30Dhx5abkt4MzEsmMU40DWUnw24p39ZELPpt72qmZcVeVdL_XYcXr9iAIvsAv-I38MnrLxpdfbz5fi95dQQStbCOCTYc2ujwBH6BESEB7B5kzacwCaBswMoLElGCtMaXNNFAwiBAi78Vk6NQe26rqCt4xXjpMLJ22KmAwmQTncxlBKiUBsxGfmgFLlp-yCL30ODlgTAtKQQiI4hmIogViwD6tutx3uhv_a_xhiU-Bq4N-ebgK6vmsSHNyHKTq3gHb7_BaDbcEesDsGpKrBqS8vf6kuv3ZKnAPLe2_5e__OeYB25bE_7T_bA_ZVvMwhyOMXhp_zDavJulxOzOfAOu_9Lg |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Age-related+modulation+of+plasmatic+beta-Galactosidase+activity+in+healthy+subjects+and+in+patients+affected+by+T2DM&rft.jtitle=Oncotarget&rft.au=Spazzafumo%2C+Liana&rft.au=Mens%C3%A0%2C+Emanuela&rft.au=Matacchione%2C+Giulia&rft.au=Galeazzi%2C+Tiziana&rft.date=2017-11-07&rft.eissn=1949-2553&rft.volume=8&rft.issue=55&rft.spage=93338&rft_id=info:doi/10.18632%2Foncotarget.21848&rft_id=info%3Apmid%2F29212153&rft.externalDocID=29212153 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-2553&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-2553&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-2553&client=summon |